Francesco Rusconi

Francesco Rusconi

Auto-generated profile, based on publicly available information

Francesco Rusconi

Unit of Cell and Gene Therapies, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ACAlessandro Cherubini
Alessandro Cherubini
MBMario Barilani
Mario Barilani
Riccardo Lorenzo RossiRiccardo Lorenzo Rossi
Riccardo Lorenzo Rossi
MJMurtadhah M K Jalal
Murtadhah M K Jalal
FRFrancesco Rusconi
Francesco Rusconi
Lorenza LazzariLorenza Lazzari
Lorenza Lazzari
Stem cell identity and plasticity are controlled by master regulatory genes and complex circuits also involving non-coding RNAs. Circular RNAs (circRNAs) are a class of RNAs generated from protein-coding genes by backsplicing, resulting in stable RNA structures devoid of free 5’ and 3’ ends. Little is known of the mechanisms of action of circRNAs, let alone in stem cell biology. In this study, for the first time, we determined that a circRNA controls mesenchymal stem cell (MSC) identity and differentiation. High-throughput MSC expression profiling from different tissues revealed a large number of expressed circRNAs. Among those, circFOXP1 was enriched in MSCs compared to differentiated mesodermal derivatives. Silencing of circFOXP1 dramatically impaired MSC differentiation in culture and in vivo. Furthermore, we demonstrated a direct interaction between circFOXP1 and miR-17–3p/miR-127–5p, which results in the modulation of non-canonical Wnt and EGFR pathways. Finally, we addressed the interplay between canonical and non-canonical Wnt pathways. Reprogramming to pluripotency of MSCs reduced circFOXP1 and non-canonical Wnt, whereas canonical Wnt was boosted. The opposing effect was observed during generation of MSCs from human pluripotent stem cells. Our results provide unprecedented evidence for a regulatory role for circFOXP1 as a gatekeeper of pivotal stem cell molecular networks.

6 August 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CFCinzia Ferrario
Cinzia Ferrario
FRFrancesco Rusconi
Francesco Rusconi
APAlbana Pulaj
Albana Pulaj
RMRaffaella Macchi
Raffaella Macchi
PLPaolo Landini
Paolo Landini
MSMichela Sugni
Michela Sugni
Collagen-based skin-like scaffolds (CBSS) are promising alternatives to skin grafts to repair wounds and injuries. In this work, we propose that the common marine invertebrate sea urchin represents a promising and eco-friendly source of native collagen to develop innovative CBSS for skin injury treatment. Sea urchin food waste after gonad removal was here used to extract fibrillar glycosaminoglycan (GAG)-rich collagen to produce bilayer (2D + 3D) CBSS. Microstructure, mechanical stability, permeability to water and proteins, ability to exclude bacteria and act as scaffolding for fibroblasts were evaluated. Our data show that the thin and dense 2D collagen membrane strongly reduces water evaporation (less than 5% of water passes through the membrane after 7 days) and protein diffusion (less than 2% of BSA passes after 7 days), and acts as a barrier against bacterial infiltration (more than 99% of the different tested bacterial species is retained by the 2D collagen membrane up to 48 h), thus functionally mimicking the epidermal layer. The thick sponge-like 3D collagen scaffold, structurally and functionally resembling the dermal layer, is mechanically stable in wet conditions, biocompatible in vitro (seeded fibroblasts are viable and proliferate), and efficiently acts as a scaffold for fibroblast infiltration. Thus, thanks to their chemical and biological properties, CBSS derived from sea urchins might represent a promising, eco-friendly, and economically sustainable biomaterial for tissue regenerative medicine.

24 April 2023 in Biochemical Engineering Journal
Verified
Journal Article
Closed access
VPValeria Peli
Valeria Peli
MBMario Barilani
Mario Barilani
ARAraceli Rivera-Ordaz
Araceli Rivera-Ordaz
PMPaolo Manzini
Paolo Manzini
FRFrancesco Rusconi
Francesco Rusconi
Lorenza LazzariLorenza Lazzari
Lorenza Lazzari

20 March 2025 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
ACAlessandro Cherubini
Alessandro Cherubini
CPClelia Pistoni
Clelia Pistoni
MIMaria Chiara Iachini
Maria Chiara Iachini
CMCecilia Mei
Cecilia Mei
FRFrancesco Rusconi
Francesco Rusconi
Lorenza LazzariLorenza Lazzari
Lorenza Lazzari
Mesenchymal stromal cells (MSC) play a critical role in the stem cell niche, a specialized microenvironment where stem cells reside and interact with surrounding cells and extracellular matrix components. Within the niche, MSC offer structural support, modulate inflammatory response, promote angiogenesis and release specific signaling molecules that influence stem cell behavior, including self-renewal, proliferation and differentiation. In epithelial tissues such as the intestine, stomach and liver, MSC act as an important source of cytokines and growth factors, but not much is known about their role in the pancreas. Our group has established a standardized technology for the generation of pancreatic organoids. Herein, we investigated the role of pancreatic mesenchymal stromal cells in the regulation of human pancreatic organoid proliferation and growth, using this 3D model in a co-culture system. We particularly focused on the capacity of pancreatic MSC to produce R-spondin factors, which are considered critical regulators of epithelial growth. We propose the development of a complex in vitro system that combines organoid technology and mesenchymal stromal cells, thereby promoting the assembloid new research era.